The chief information officer of the 25-bed New Mexico nonprofit discusses plan for some new clinical automation tools. He also describes how he's using AI to help with network defense, and how that's enabling gains in other areas.

The U.S. Food and Drug Administration's validation requirements process for drug development is a good model for healthcare artificial intelligence governance, explains Michael Abrams, managing partner at Numerof & Associates.

The Philadelphia health system has committed to returning 10 million hours back to patient care over the next three years using AI, says Dr. Baligh Yehia, president of Jefferson Health.

Eitan Okun, head of the Paul Feder Laboratory for Alzheimer's Disease Research at Bar-Ilan University, discusses the lab's study on the mechanistic link between pregnancy with a Down syndrome fetus and an elevated risk of maternal cognitive decline.